Sulfasalazine is a prescription anti-inflammatory medicine used mainly for ulcerative colitis and, in its enteric-coated form, for rheumatoid arthritis. Azulfidine is the brand name. The plain tablet is called Azulfidine, and the coated, delayed-release version is Azulfidine EN-tabs. It has been in use for decades, it works slowly, and it needs regular blood tests, which is why people who take it should understand what to watch for.
This guide covers what sulfasalazine treats, how it works, the difference between the two tablet forms, typical dosing from the label, the side effects and serious warnings, the blood monitoring schedule, folic acid, fertility and pregnancy points, and answers to common questions.
This is general information based on FDA-approved labeling, not medical advice. Your doctor sets the dose and the monitoring schedule for you.
Sulfasalazine at a glance
| Drug class | Aminosalicylate anti-inflammatory (a combination of 5-ASA and a sulfa antibiotic) |
|---|---|
| Brand names | Azulfidine (plain tablets), Azulfidine EN-tabs (delayed-release), plus generics |
| Approved for | Ulcerative colitis; EN-tabs also for rheumatoid arthritis and polyarticular juvenile rheumatoid arthritis |
| Typical form | 500 mg tablets, taken in divided doses, preferably after meals |
| Onset | Slow. Arthritis benefit may take weeks. A response has been seen as early as 4 weeks |
| Needs monitoring | Yes: complete blood counts and liver tests |
| Common visible effect | Orange-yellow discoloration of urine or skin |
What sulfasalazine is and how it works
Sulfasalazine is built from two smaller molecules joined together: 5-aminosalicylic acid (5-ASA, also called mesalamine or mesalazine), an anti-inflammatory, and sulfapyridine, a sulfa antibiotic. After the tablet reaches the colon, bacteria in the gut split the drug into these two parts.
In ulcerative colitis, studies described in the label point to the 5-ASA part as the main source of the benefit. It acts on the lining of the colon and reduces inflammation there. The sulfapyridine part is absorbed into the bloodstream and is responsible for many of the side effects. The label states that the relative contribution of the parent drug and its metabolites in rheumatoid arthritis is unknown, so the exact way it helps in arthritis is less clear.
That split explains an important idea: newer 5-ASA drugs such as mesalamine deliver the anti-inflammatory part without the sulfa part. See our comparison of sulfasalazine vs mesalamine for how doctors weigh the two.
What sulfasalazine treats
Ulcerative colitis
The Azulfidine tablet label lists these uses:
- Treatment of mild to moderate ulcerative colitis
- Adjunctive therapy in severe ulcerative colitis
- Prolonging the remission period between acute attacks
The label also stresses that ulcerative colitis rarely goes away completely and that the chance of relapse can be substantially lowered by staying on a maintenance dose. Feeling well is not a reason to stop.
Rheumatoid arthritis (EN-tabs)
The delayed-release Azulfidine EN-tabs are also approved for rheumatoid arthritis in adults who have not responded adequately to salicylates or other NSAIDs, and for polyarticular-course juvenile rheumatoid arthritis. The label notes that, unlike anti-inflammatory pain relievers, it does not give an immediate response. A response has been observed as early as 4 weeks after starting, so patience and follow-up matter. The label also says rest and physiotherapy should be continued.
EN-tabs are also indicated for ulcerative colitis in patients who cannot take uncoated sulfasalazine because of stomach upset, provided the intolerance is not mainly due to high blood levels of sulfapyridine.
Plain tablets vs EN-tabs
| Azulfidine (plain) | Azulfidine EN-tabs (delayed-release) | |
|---|---|---|
| Coating | None | Enteric coating that resists stomach acid |
| Approved for | Ulcerative colitis | Ulcerative colitis, rheumatoid arthritis, juvenile rheumatoid arthritis |
| Stomach upset | More likely | Often better tolerated |
| Notes | Standard for ulcerative colitis | Swallow whole; do not crush or chew |
Both contain the same active drug. The coating delays release until the tablet is past the stomach, which can ease nausea and stomach pain. Do not crush or chew the EN-tabs.
Dosing from the label
Only your doctor should set your dose. These are the figures printed on the Azulfidine label, given so you can follow the conversation with your care team.
| Use | Adults | Children 6 and older |
|---|---|---|
| Starting therapy (ulcerative colitis) | 3 to 4 g a day in evenly divided doses, intervals not over 8 hours | 40 to 60 mg per kg per 24 hours, in 3 to 6 doses |
| Maintenance | 2 g a day | 30 mg per kg per 24 hours, in 4 doses |
Some patients start on a smaller dose, such as 1 to 2 g a day, to reduce stomach upset. The label warns that daily doses above 4 g raise the risk of toxicity. It advises taking the medicine in evenly divided doses, preferably after meals, and notes that medication often needs to continue even after diarrhea and other symptoms are controlled.
Response in ulcerative colitis is judged by symptoms such as fever, weight changes, and the frequency of diarrhea and bleeding, and can be checked by sigmoidoscopy and biopsy.
Side effects
The most common side effects listed on the label are:
- Loss of appetite
- Headache
- Nausea and vomiting
- Stomach upset
- Reduced sperm count (oligospermia) in men
Others patients commonly report include rash and tiredness. The label also says sulfasalazine can turn urine or skin an orange-yellow color. This is harmless in itself, though it can stain skin, and it can discolor soft contact lenses.
Taking it after meals, using the EN-tab form, or raising the dose gradually can reduce the stomach effects. Do not change the schedule without checking with your doctor.
Serious warnings
Sulfasalazine has some rare but serious risks, and most of them are the reason for regular monitoring.
Blood disorders and liver injury
The label warns that deaths have been reported with sulfasalazine, and it names hypersensitivity reactions, blood disorders such as agranulocytosis and aplastic anemia, and liver and kidney damage among the causes. It says signs such as sore throat, fever, pallor, purpura (small bruise-like spots), or jaundice may indicate a serious blood disorder or liver injury. If those appear, the label says to stop the drug while blood test results are checked.
Contact your doctor at once for a sore throat or fever that will not go away, unusual bruising or bleeding, pale skin, severe fatigue, or yellowing of the skin or eyes.
Severe skin and allergic reactions
Serious rashes and allergic reactions, including severe skin reactions such as Stevens-Johnson syndrome, have been reported with sulfa drugs. Stop the medicine and get urgent care if you develop a spreading rash, blisters, peeling skin, mouth sores, or swelling of the face.
Sulfa and salicylate allergy
Sulfasalazine contains a sulfa component and a salicylate component. It is contraindicated in people who are hypersensitive to sulfonamides or salicylates, and it should not be used in those with certain blockages in the intestine or urinary tract or with porphyria. Tell your doctor about any sulfa or aspirin allergy before starting.
Infection
The current EN-tabs labeling advises that a patient who develops a new infection during treatment should have a prompt and complete diagnostic workup.
Blood tests and monitoring
The label calls for regular laboratory monitoring. A complete blood count with differential, and liver function tests, should be done before starting sulfasalazine and every second week during the first three months of therapy. Complete blood counts and urinalysis with careful microscopy should be done frequently in patients receiving it. Many doctors then space out testing if results stay stable, though the schedule depends on your situation.
Do not skip lab appointments. Serious blood problems can develop without obvious early symptoms, and these tests are how they are caught in time.
Folic acid
Sulfasalazine can make it harder for the body to absorb folic acid, a B vitamin needed for making new blood cells and, in pregnancy, for the developing baby’s spine and brain. Many doctors therefore prescribe or recommend folic acid alongside sulfasalazine. Our guide to sulfasalazine and folic acid explains when and why. Do not start supplements without checking with your doctor first.
Fertility, pregnancy, and breastfeeding
The label states that oligospermia and infertility have been observed in men treated with sulfasalazine, and that these effects appear to reverse when the drug is withdrawn. Men who want to father a child should discuss this with their doctor, who may consider switching to another drug for a while.
For pregnancy and breastfeeding, the decision depends on disease activity and the alternatives. Untreated ulcerative colitis can itself be risky during pregnancy, and many people with inflammatory bowel disease do continue treatment under supervision, often with extra folic acid. Talk to your doctor and, if possible, a gastroenterologist or rheumatologist before you conceive.
Drug interactions and other cautions
Tell your doctor and pharmacist about everything you take. Sulfasalazine can affect how the body handles certain drugs, including some blood thinners and diabetes medicines, and it can interact with drugs that also affect blood counts or the liver. It can lower absorption of digoxin and folate. Avoid combining it with other sulfa drugs unless a doctor approves.
Some people should be more cautious, including anyone with kidney or liver disease, G6PD deficiency, severe allergies or asthma, or a history of blood disorders.
Sulfasalazine compared with other options
- Mesalamine and other 5-ASA drugs. They deliver the anti-inflammatory part without the sulfa part, and they are often easier to tolerate, though they do not treat arthritis in the same way.
- Methotrexate, leflunomide, and biologics for arthritis. These are other options for rheumatoid arthritis, chosen based on how active the disease is and what has been tried. Sulfasalazine is often used alone or in combination with other disease-modifying drugs.
- Immunosuppressants for colitis. For more severe or stubborn bowel disease, doctors may add drugs such as azathioprine. See our guide to azathioprine.
What to expect: colitis vs arthritis
In ulcerative colitis, the goal is to calm inflammation in the colon during a flare and then keep the disease quiet with a maintenance dose. Many people notice fewer bowel movements, less bleeding, and less urgency over the first weeks, although the pace varies. Doctors judge the response by symptoms such as diarrhea frequency, blood in the stool, fever, and weight, and sometimes by looking inside the colon. Because relapse is common when treatment stops, most people stay on a maintenance dose for a long time. Your doctor will decide whether sulfasalazine is enough or whether another drug needs to be added.
In rheumatoid arthritis, sulfasalazine is a disease-modifying drug, not a painkiller. It aims to slow joint damage and reduce swelling over time. It will not work like ibuprofen, and you may still need a pain reliever or other arthritis medicine in the meantime. Improvement can start around 4 weeks in some patients and may take longer in others. The label says rest and physiotherapy should continue alongside medication.
Living with sulfasalazine: practical tips
- Take it with food. The label recommends taking it in evenly divided doses, preferably after meals, which reduces nausea and stomach pain.
- Do not skip doses to “save” them. The medicine works best when levels stay steady, so spread doses evenly across the day.
- Swallow EN-tabs whole. Crushing or chewing removes the coating that protects your stomach.
- Drink plenty of fluids. Good hydration is a sensible habit with sulfa drugs and helps your kidneys.
- Protect your skin from the sun. Some sulfa drugs can make skin more sensitive to sunlight. Use sunscreen and cover up until you know how you react.
- Expect the color change. Orange-yellow urine is harmless and expected, and it can stain clothing or soft contact lenses.
- Keep every lab appointment. Blood counts and liver tests are the safety net that catches problems early.
- Tell every clinician you see that you take sulfasalazine, including your dentist and any surgeon, since it can affect blood counts and interact with other medicines.
- Bring a list of medicines and supplements to each visit so interactions can be checked.
- Do not stop suddenly. Stopping without guidance during ulcerative colitis can lead to relapse.
When to get urgent medical help
Call your doctor right away or seek emergency care if you have:
- A sore throat, fever, or infection that does not go away, or you get sick often
- Unusual bruising, bleeding, or small purple or red spots on the skin
- Pale skin, extreme tiredness, or shortness of breath
- Yellowing of the skin or eyes, dark urine with pain, or severe upper abdominal pain
- A widespread rash, blisters, peeling skin, mouth sores, or swelling of the face, lips, or throat
- Difficulty breathing, wheezing, or a cough that is new or worsening
- Little or no urination, swelling in the legs, or puffy eyes
- Severe bloody diarrhea or belly pain that is getting worse
These may be signs of the serious blood, liver, kidney, lung, skin, or allergic reactions described in the label. Getting help early makes a big difference.
Questions to ask your doctor
- Is sulfasalazine the best choice for me, or would a mesalamine drug or another treatment be better?
- Should I take the plain tablet or the EN-tab form?
- What is my dose, and how will it change over time?
- How often will I need blood tests, and what would make you stop the drug?
- Should I take folic acid, and how much?
- How will this affect fertility, pregnancy, or breastfeeding plans?
- Which of my other medicines could interact with it?
- What symptoms should make me call you the same day?
Frequently asked questions
Are Azulfidine and sulfasalazine the same thing?
Yes. Azulfidine is the brand name of sulfasalazine. Azulfidine EN-tabs is the delayed-release form. Generic sulfasalazine contains the same active ingredient.
How long does sulfasalazine take to work?
It is slow. In arthritis, the label notes that unlike anti-inflammatory pain relievers it does not produce an immediate response, and improvement has been seen as early as 4 weeks. In ulcerative colitis, symptoms are followed over time and doses are adjusted.
Why is my urine orange?
Sulfasalazine can produce an orange-yellow discoloration of the urine or skin. The label lists this as an expected effect. Tell your doctor if you also have yellowing of the eyes, dark urine with pain, or other symptoms.
Do I need blood tests?
Yes. The label calls for a complete blood count with differential and liver function tests before starting and every second week for the first three months, and blood counts and urinalysis regularly after that.
Should I take folic acid with sulfasalazine?
Sulfasalazine can reduce folic acid absorption, so doctors often recommend it. Ask your doctor before starting, and do not begin a high-dose supplement on your own.
Can sulfasalazine affect fertility?
In men, yes. The label reports oligospermia and infertility, which appear to reverse after stopping the drug. Discuss family planning with your doctor.
Can I take sulfasalazine if I’m allergic to sulfa drugs or aspirin?
No. It is contraindicated in people who are hypersensitive to sulfonamides or salicylates. Tell your doctor about any such allergy.
Can I stop sulfasalazine when my symptoms go away?
Not without your doctor’s advice. The label explains that ulcerative colitis rarely remits completely and that staying on a maintenance dose reduces the chance of relapse.
What is the difference between Azulfidine and Azulfidine EN-tabs?
Both contain sulfasalazine. The EN-tab has a coating that dissolves past the stomach, which can reduce nausea, and it is also approved for rheumatoid arthritis and juvenile rheumatoid arthritis. The plain tablet is approved for ulcerative colitis.
Related Reading
- Azulfidine (Sulfasalazine): Uses and Warnings
- Sulfasalazine and Folic Acid: Why They're Taken Together
References
- Pfizer. AZULFIDINE (sulfasalazine) tablets, USP: prescribing information.
- Pfizer. AZULFIDINE EN-tabs (sulfasalazine delayed release tablets, USP): prescribing information.
- FDA. Azulfidine (sulfasalazine) tablets, label (2009): laboratory monitoring, oligospermia, urine discoloration.
- FDA. Azulfidine EN-tabs (sulfasalazine delayed release tablets), label (2012).
- Pfizer Medical. AZULFIDINE dosage and administration.
- Drugs.com. Sulfasalazine: uses, dosage, side effects, warnings.